1-3 of 3
Elena Bogdanova
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prospective Study to Evaluate the Efficacy and Safety of Gemcitabine Combined with GMCSF and Rituximab in Heavily Pre-Treated Relapsed / Refractory B-Lymphoproliferative Disorders

Shinoj Pattali, MD, Stephanie A. Gregory, Melissa Leigh Larson, MD, Jamile M. Shammo, MD, Elena Bogdanova, CCRP, Teresa Obrien, RN, BS, Parameswaran Venugopal, MD
Journal: Blood
Blood (2011) 118 (21): 1616.
https://doi.org/10.1182/blood.V118.21.1616.1616
Published: 2011
Journal Articles

ESHAP with Rituximab Is Highly Efficacious with Durable Responses in Patients with Relapsed/Refractory Aggressive Non-Hodgkin’s Lymphoma.

Rekha R. Threja, MD, Parameswaran Venugopal, MD, Stephanie A. Gregory, MD, Teresa O’Brien, RN, Elena Bogdanova
Journal: Blood
Blood (2005) 106 (11): 4787.
https://doi.org/10.1182/blood.V106.11.4787.4787
Published: 2005
Journal Articles

Radioimmunotherapy with I 131 Tositumomab in Relapsed and Transformed Low-Grade (LG) Non-Hodgkin’s Lymphoma (NHL): Long-Term Follow-Up of a Single Institution Experience.

Huma Qawi, Teresa M. O’Brien, Parameswaran Venugopal, Jamile Shammo, Elena Bogdanova, Stephanie A. Gregory
Journal: Blood
Blood (2004) 104 (11): 4641.
https://doi.org/10.1182/blood.V104.11.4641.4641
Published: 2004